Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus



Status:Completed
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 80
Updated:4/21/2016
Start Date:December 2009
End Date:September 2010

Use our guide to learn which trials are right for you!

A Phase 2, Randomized, Double-Blind, Double-Dummy Placebo-and Active-Controlled, Multicenter Study to Determine the Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus

The purpose of this study is to determine the safety and efficacy of multiple doses of
TAK-875, once daily (QD), in subjects with Type 2 Diabetes Mellitus.

TAK-875 is under clinical development for the treatment of type 2 diabetes mellitus in
humans. Non-clinical as well as Phase I clinical data suggest that TAK-875 stimulates
insulin secretion only at elevated blood glucose levels.

This study is being conducted to study glycemic effects and safety of TAK-875 compared with
placebo and glimepiride in subjects with type 2 diabetes who are inadequately controlled on
a stable dose of metformin as monotherapy.

Subjects participating in this study are required to fast for 8 hours prior to each study
visit, and will be educated in recognition and self-management of hypoglycemia. In addition,
during this Run-in Period compliance with study medication will be documented. Subjects who
are less than 80% or more than120% compliant with the single-blind, placebo regimen during
the run-in period will not be randomized.

At the conclusion of the Run-in period, appropriate subjects will be randomized into the 12
week double-blind treatment period.

Inclusion Criteria:

- Participant meets 1 of the following criteria:

- A historical diagnosis of type 2 diabetes mellitus without the chronic use of
antidiabetic therapy within 8 weeks prior to Screening, and with at least an
8-week documented history of a diet and exercise plan at Screening.

- A historical diagnosis of mellitus and stable on at least 1500 mg per day or the
respective (individually) maximal tolerated dose of metformin as monotherapy for
at least 2 months prior to Screening.

- Has a glycosylated hemoglobin level at Screening between 7.5% and 10.0%, inclusive,
if on metformin and greater than or equal to 7.5% to less than 11% if treated with
diet and exercise alone.

- Has a fasting plasma glucose level less than 260 mg/dL, at Screening.

- Has a fasting C-peptide concentration greater than or equal to 0.8 ng/mL at
Screening.

- If participant takes any chronic medications, the dose of these medications must have
been stable (no change in dose or drug) for at least 4 weeks prior to Screening.

- Participant's body mass index at Screening is greater than or equal to 23 and less
than or equal to 45 kg/m2.

- Is able and willing to monitor glucose with a home glucose monitor and consistently
record his or her own blood glucose concentrations.

- Females of childbearing potential who are sexually active must agree to use a
medically accepted means of contraception, and can neither be pregnant nor lactating
from Screening throughout the duration of the study and for 1 month after the last
dose of study drug.

- Compliance with single-blind study medication during the Run-in Period is at least
80% and does not exceed 120% based on tablet counts performed by the study staff.

Exclusion Criteria:

- Has systolic blood pressure greater than 160 mm Hg or diastolic pressure greater than
100 mm Hg at Screening or Baseline (as confirmed by repeat measurement 30 minutes
after initial measurement).

- Has history of cancer that has been in remission for less than 5 years prior to
Screening. A history of basal cell carcinoma or stage 1 squamous cell carcinoma of
the skin is allowed.

- Has a creatine phosphokinase level greater than or equal to 5 times the upper limit
of normal at Screening.

- Has a hemoglobin level of less than or equal to 12 g/dL (120 gm/L) for men and less
than or equal to 10 g/dL (100 gm/L) for women at Screening.

- Has alanine aminotransferase and aspartate aminotransferase levels greater than or
equal to 2.5 times upper limit of normal at Screening.

- Has a total bilirubin level greater than or equal to 1.5 mg/dL at Screening.

- The subject has a serum triglyceride concentration greater than or equal to 400 mg/dL
at Screening.

- Has an estimated glomerular filtration rate less than or equal to 60 mL/min using the
Modification of Diet in Renal Disease equation at Screening.

- Has abnormal thyroid-stimulating hormone levels.

- Has a positive test result for hepatitis B surface antigen or hepatitis C antibody or
human immunodeficiency virus.

- Has macro-albuminuria at Screening

- Has a history of laser treatment for proliferative diabetic retinopathy within 6
months prior to Screening.

- Has diabetic gastroparesis that in the investigator's opinion is moderate or severe
and hence may impair absorption of study medication.

- Has had coronary angioplasty, coronary stent placement, coronary bypass surgery,
myocardial infarction, unstable angina pectoris, clinically significant abnormal
electrocardiogram, cerebrovascular accident or transient ischemic attack within 6
months prior or at Screening.

- Has a history of any hemoglobinopathy that may affect determination of glycosylated
hemoglobin.

- Received treatment with probucol within 1 year of randomization.

- Donated or received any blood products within 12 weeks prior to Screening.

- Received treatment for more than 7 days within 4 weeks or 8 weeks (depending on the
medication) prior to Screening.

- Is on any insulin treatment.

- Received any investigational drug within 4 weeks prior to Screening.

- Is hypersensitive to TAK-875, its excipients or glimepiride.

- Has a history of drug abuse or a history of alcohol abuse within 2 years prior to
Screening.

- Has any other physical or psychiatric disease or condition that in the judgment of
the investigator may affect life expectancy or may make it difficult to successfully
manage and follow the subject according to the protocol.

- Is required to take or intends to continue taking any disallowed medication, any
prescription medication, herbal treatment or over-the counter medication that may
interfere with evaluation of the study medication, including:

- Probucol

- Chronically used insulin

- Chronically used oral or parenteral glucocorticoids

- Chronically used over-the-counter or prescription weight-loss medications and/or
Orlistat Niacin more than 200 mg/day, including niacin-containing products such
as Advicor®

- Chronically used peroxisome proliferator-activated receptor agonists, ezetimibe,
oral or injectable hypoglycemic agents other than metformin bile-acid binding
agents such as cholestyramine and colesevelam

- Investigational medications

- Warfarin and phenytoin
We found this trial at
65
sites
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
2203
mi
from 91732
Altoona, PA
Click here to add this to my saved trials
16
mi
from 91732
Anaheim, CA
Click here to add this to my saved trials
?
mi
from 91732
Asheboro, NC
Click here to add this to my saved trials
2388
mi
from 91732
Berlin, NJ
Click here to add this to my saved trials
1784
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
2312
mi
from 91732
Boca Raton, FL
Click here to add this to my saved trials
342
mi
from 91732
Burlingame, CA
Click here to add this to my saved trials
Burlington, North Carolina 27215
2171
mi
from 91732
Burlington, NC
Click here to add this to my saved trials
2377
mi
from 91732
Camden, NJ
Click here to add this to my saved trials
1890
mi
from 91732
Carlisle, OH
Click here to add this to my saved trials
Charlotte, North Carolina 28207
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
113
mi
from 91732
Chula Vista, CA
Click here to add this to my saved trials
2117
mi
from 91732
Clearwater, FL
Click here to add this to my saved trials
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Colorado Springs, Colorado 80910
804
mi
from 91732
Colorado Springs, CO
Click here to add this to my saved trials
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
1293
mi
from 91732
Corpus Christi, TX
Click here to add this to my saved trials
2559
mi
from 91732
Cranston, RI
Click here to add this to my saved trials
558
mi
from 91732
Draper, UT
Click here to add this to my saved trials
207
mi
from 91732
Fresno, CA
Click here to add this to my saved trials
2138
mi
from 91732
Guatemala,
Click here to add this to my saved trials
2315
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
2573
mi
from 91732
Honolulu, HI
Click here to add this to my saved trials
1787
mi
from 91732
Hoover, AL
Click here to add this to my saved trials
1201
mi
from 91732
Hurst, TX
Click here to add this to my saved trials
2295
mi
from 91732
Jupiter, FL
Click here to add this to my saved trials
1562
mi
from 91732
La Grange, IL
Click here to add this to my saved trials
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
311
mi
from 91732
Los Gatos, CA
Click here to add this to my saved trials
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Morehead City, North Carolina 28557
2335
mi
from 91732
Morehead City, NC
Click here to add this to my saved trials
2114
mi
from 91732
New Port Richey, FL
Click here to add this to my saved trials
1169
mi
from 91732
Norman, OK
Click here to add this to my saved trials
North Richland Hills, Texas 76180
1199
mi
from 91732
North Richland Hills, TX
Click here to add this to my saved trials
12
mi
from 91732
Norwalk, CA
Click here to add this to my saved trials
2128
mi
from 91732
Ocala, FL
Click here to add this to my saved trials
919
mi
from 91732
Odessa, TX
Click here to add this to my saved trials
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Olive Branch, Mississippi 38654
1599
mi
from 91732
Olive Branch, MS
Click here to add this to my saved trials
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
1904
mi
from 91732
Panama City, FL
Click here to add this to my saved trials
2305
mi
from 91732
Parkville, MD
Click here to add this to my saved trials
2086
mi
from 91732
Peak, SC
Click here to add this to my saved trials
2306
mi
from 91732
Pembroke Pines, FL
Click here to add this to my saved trials
1932
mi
from 91732
Perrysburg, OH
Click here to add this to my saved trials
2614
mi
from 91732
Portland, ME
Click here to add this to my saved trials
800
mi
from 91732
Pueblo, CO
Click here to add this to my saved trials
2275
mi
from 91732
Rockville, MD
Click here to add this to my saved trials
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
1917
mi
from 91732
Sandy Springs, GA
Click here to add this to my saved trials
1958
mi
from 91732
Southfield, MI
Click here to add this to my saved trials
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Statesville, North Carolina 28677
2093
mi
from 91732
Statesville, NC
Click here to add this to my saved trials
1533
mi
from 91732
Sunset, LA
Click here to add this to my saved trials
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
2022
mi
from 91732
Taylors, SC
Click here to add this to my saved trials
2208
mi
from 91732
Tipton, PA
Click here to add this to my saved trials
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Varnville, South Carolina 29944
2118
mi
from 91732
Varnville, SC
Click here to add this to my saved trials
2187
mi
from 91732
West Seneca, NY
Click here to add this to my saved trials
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials